$33.00
Lira 500 is indicated for use:
- with a stroke, as well as complications after suffering from circulatory disorders of the brain;
- with craniocerebral trauma, neurological disorders after it;
- with neurological disorders (sensitive, cognitive, motor), which are caused by chronic vascular / degenerative pathologies of the brain.
Description
Lira 500 composition
active substance: citicoline;
1 ampoule (4 ml) contains 500 mg of sodium citicoline in terms of 100% substance;
auxiliary substances: concentrated hydrochloric acid or sodium hydroxide, water for injection.
Dosage form
Injection.
Pharmacological properties
It is a nootropic and psychostimulant. It helps to eliminate cognitive disorders (cognitive disorders), neurological disorders associated with cerebral ischemia, increase alertness, and improve memory.
Indications
Lira 500 is indicated for use:
- with a stroke, as well as complications after suffering from circulatory disorders of the brain;
- with craniocerebral trauma, neurological disorders after it;
- with neurological disorders (sensitive, cognitive, motor), which are caused by chronic vascular / degenerative pathologies of the brain.
Contraindications
You can not use Lyra in case of intolerance to the components, increased tone of the parasympathetic nervous system. This drug is not used to treat children.
Application during pregnancy and lactation
The use of Lira during these periods is allowed if the expected positive effect of its use on the woman’s health significantly outweighs the risks to the health of the fetus / child.
Method of administration and dosage
Lira 500 is administered parenterally – intramuscularly or intravenously.
Lira is administered intravenously in the form of slow injections (depending on the dose, it is administered over three to five minutes) or intravenously (at a rate of forty to sixty drops / minute).
The recommended dose, depending on the actual clinical condition of the patient, is 500–2000 mg / day. The maximum dose that can be applied per day is 2000 mg.
In acute and urgent conditions, the maximum therapeutic effect can be achieved when applied in the first twenty-four hours.
The dose and duration of the course of therapy depend on the severity of the brain damage in the patient and are set by the treating doctor individually in each clinical case. The recommended course of therapy with this drug is twelve weeks.
The solution must be administered immediately after opening the ampoule. The remains of the unused medicine must be disposed of.
Lira solution is compatible with all isotonic solutions administered intravenously, as well as compatible with hypertonic glucose solutions.
Overdose
Overdose cases with this medicine have not been described. In case of intentional or accidental use of high doses of the drug, it is necessary to stop treatment and consult with your doctor.
Side effects
Side effects that may develop during treatment include: severe headache, vertigo (dizziness), nausea, chills, hallucinations, tachycardia (heart palpitations), diarrhea, fever, arterial hyper / hypotension, edema, hyperhidrosis (excessive sweating) , shortness of breath, vomiting.
Allergic reactions of varying severity can also develop: skin rashes, urticaria, purpura, itching, anaphylactic shock, angioedema.
There may also be changes (inflammation, redness, swelling, soreness) at the injection site.
Storage conditions and periods
It is required to store / transport Lear’s solution in its original packaging at a temperature between 15-30 ° С. The shelf life of this pharmaceutical product is two years. Its use after the expiration date is prohibited. The medicine should be kept out of the reach of the child.
Recent Reviews